Board of Directors of CytoDyn Inc. terminated the employment of Nader Z. Pourhassan, Ph.D. CEO of the Company, effective January 24, 2022. The rest of CytoDyn's executive team is continuing with the Company and is united in their commitment to advance the Company's objectives.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.15 USD | -1.70% | -4.94% | -23.08% |
05-30 | Transcript : CytoDyn Inc. - Special Call | |
05-03 | CytoDyn Inc. announced that it has received $8.942 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-23.08% | 159M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- CYDY Stock
- News CytoDyn Inc.
- CytoDyn Announces Executive Changes